Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000400818

Medchemexpress LLC Pomalidomide-PEG4-C-COOH | 2097938-44-6 | 99.19% | 507.49 | 50 MG
SDP

Catalog No. 5000400818
Encompass_Preferred

Pomalidomide-PEG4-C-COOH (Cereblon Ligand -Linker Conjugate 1) is a synthesized E3 ligase ligand-linker conjugate that incorporates a Pomalidomide-based cereblon ligand and a 4-unit PEG linker, which are components used in PROTAC technology. PROTACs utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • A synthesized E3 ligase ligand-linker conjugate.
  • Incorporates Pomalidomide based cereblon ligand.
  • Includes a 4-unit PEG linker.
  • Used in PROTAC technology.
  • Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

Catalog No. 50-004-00818 Supplier Medchemexpress LLC Supplier No. HY2193050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pomalidomide-PEG4-C-COOH (Cereblon Ligand -Linker Conjugate 1) is a synthesized E3 ligase ligand-linker conjugate that incorporates a Pomalidomide-based cereblon ligand and a 4-unit PEG linker, which are components used in PROTAC technology. PROTACs utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • A synthesized E3 ligase ligand-linker conjugate.
  • Incorporates Pomalidomide based cereblon ligand.
  • Includes a 4-unit PEG linker.
  • Used in PROTAC technology.
  • Exploits the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.